Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Answers to burning questions for clinical allergologists related to the new COVID-19 vaccines.
Altrichter S, Wöhrl S, Horak F, Idzko M, Jordakieva G, Untersmayr E, Szepfalusi Z, Zieglmayer P, Jensen-Jarolim E, Wiedermann U, Rosenkranz A, Hötzenecker W. Altrichter S, et al. Among authors: zieglmayer p. Allergo J Int. 2021;30(5):169-175. doi: 10.1007/s40629-021-00177-3. Epub 2021 Jul 14. Allergo J Int. 2021. PMID: 34277326 Free PMC article. Review.
Clinical reactivity of celery cultivars in allergic patients: Role of Api g 1.
Dölle S, Welter S, Ruppel E, Lehmann K, Schwarz D, Jensen-Jarolim E, Zieglmayer P, Franken P, Worm M. Dölle S, et al. Among authors: zieglmayer p. Clin Exp Allergy. 2018 Apr;48(4):424-432. doi: 10.1111/cea.13099. Epub 2018 Feb 28. Clin Exp Allergy. 2018. PMID: 29369458 Clinical Trial.
Clinical efficacy of sublingual immunotherapy is associated with restoration of steady-state serum lipocalin 2 after SLIT: a pilot study.
Roth-Walter F, Schmutz R, Mothes-Luksch N, Lemell P, Zieglmayer P, Zieglmayer R, Jensen-Jarolim E. Roth-Walter F, et al. Among authors: zieglmayer r, zieglmayer p. World Allergy Organ J. 2018 Oct 1;11(1):21. doi: 10.1186/s40413-018-0201-8. eCollection 2018. World Allergy Organ J. 2018. PMID: 30323863 Free PMC article.
Antworten auf brennende Fragen an klinische Allergolog*innen im Zusammenhang mit den neuen COVID-19-Impfstoffen.
Altrichter S, Wöhrl S, Horak F, Idzko M, Jordakieva G, Untersmayr E, Szepfalusi Z, Zieglmayer P, Jensen-Jarolim E, Wiedermann U, Rosenkranz A, Hötzenecker W. Altrichter S, et al. Among authors: zieglmayer p. Allergo J. 2021;30(5):48-54. doi: 10.1007/s15007-021-4847-0. Epub 2021 Aug 13. Allergo J. 2021. PMID: 34393385 Free PMC article. Review. German.
The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial.
Horak F, Zieglmayer P, Zieglmayer R, Lemell P, Collins LP, Hunter MG, Steiner J, Lewis T, Payton MA, Perkins CM, Pettipher R. Horak F, et al. Among authors: zieglmayer r, zieglmayer p. Allergy. 2012 Dec;67(12):1572-9. doi: 10.1111/all.12042. Epub 2012 Oct 1. Allergy. 2012. PMID: 23025511 Clinical Trial.
Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms.
Campana R, Marth K, Zieglmayer P, Weber M, Lupinek C, Zhernov Y, Elisyutina O, Khaitov M, Rigler E, Westritschnig K, Berger U, Wolkersdorfer M, Horak F Jr, Horak F, Valenta R. Campana R, et al. Among authors: zieglmayer p. J Allergy Clin Immunol. 2019 Mar;143(3):1258-1261. doi: 10.1016/j.jaci.2018.11.011. Epub 2018 Nov 22. J Allergy Clin Immunol. 2019. PMID: 30471304 Free PMC article. Clinical Trial. No abstract available.
Dogmas, challenges, and promises in phase III allergen immunotherapy studies.
De Kam PJ, Kramer MF, Shamji MH, Oluwayi K, Heath MD, Jensen-Jarolim E, Berger MH, Berger UE, Graessel A, Sellwood F, Zielen S, Vogelberg C, Zieglmayer P, Mösges R, Klimek L, DuBuske LM, Shreffler WG, Bernstein JA, Kündig TM, Skinner MA. De Kam PJ, et al. Among authors: zieglmayer p. World Allergy Organ J. 2021 Sep 28;14(9):100578. doi: 10.1016/j.waojou.2021.100578. eCollection 2021 Sep. World Allergy Organ J. 2021. PMID: 34659627 Free PMC article. Review.
The improved efficacy of a fixed-dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitis.
Murdoch RD, Bareille P, Ignar D, Miller SR, Gupta A, Boardley R, Zieglmayer P, Zieglmayer R, Lemel P, Horak F. Murdoch RD, et al. Among authors: zieglmayer r, zieglmayer p. Clin Exp Allergy. 2015 Aug;45(8):1346-55. doi: 10.1111/cea.12556. Clin Exp Allergy. 2015. PMID: 25900517 Clinical Trial.
60 results